Event Details

Event Description

We are pleased to invite colleagues across England to take part in the PADEL Study (Pharmacogenomics of Anti-Depressants: Economics and Life Outcomes); a major new primary care research study exploring whether pharmacogenomic-guided prescribing can improve outcomes for patients starting antidepressant treatment.

The aim of the PADEL study is to assess whether pharmacogenomic-guided prescribing can improve first-line antidepressant treatment in adults treated in UK general practice for depressive or anxiety disorders. PADEL has been specifically designed to fit alongside routine care pathways using an asynchronous recruitment model to minimise workload for practices.

​​​​​​​​​​​​​​​​​​​​​​​​​​​​Our invitation to you

Please join us at one of the following webinars held via MS Teams, to:

• Learn more about the study
• Share your experiences of the PROGRESS study
• Understand the recruitment process
• Ask questions directly to the PADEL research team
• Explore how your practice can become involved

​​​​​​​NB: All webinars will contain the same presentation and discussion, with multiple dates offered to accommodate availability.